Investors of Nektar Therapeutics Stock May Have Legal Claims – NKTR
Investors of Nektar Therapeutics Stock Since At Least June 2022 Encouraged to Contact Kehoe Law Firm, P.C. – Breach of Fiduciary Duties Investigation Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Nektar Therapeutics (“Nektar” or “Nektar... Read More →
Securities Investigation – Fulcrum Therapeutics Stock – FULC
Investors of Fulcrum Therapeutics Stock Encouraged to Contact Kehoe Law Firm, P.C. Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Fulcrum Therapeutics, Inc. (“Fulcrum” or “Fulcrum Therapeutics”) (NASDAQ: FULC). On February 24, 2023, shares... Read More →